|
C7ORF44 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66049999994478E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.72360000000516E-05 |
| Normal-vs-Stage2 |
1.596260E-02 |
| Normal-vs-Stage3 |
3.149600E-01 |
| Normal-vs-Stage4 |
2.006400E-01 |
| Stage1-vs-Stage2 |
4.041800E-01 |
| Stage1-vs-Stage3 |
1.040840E-01 |
| Stage1-vs-Stage4 |
6.265000E-01 |
| Stage2-vs-Stage3 |
8.041800E-02 |
| Stage2-vs-Stage4 |
3.742200E-01 |
| Stage3-vs-Stage4 |
5.315000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52866999999501E-05 |
| Normal-vs-AfricanAmerican |
1.137780E-03 |
| Normal-vs-Asian |
3.137600E-01 |
| Caucasian-vs-AfricanAmerican |
5.752400E-01 |
| Caucasian-vs-Asian |
7.748600E-01 |
| AfricanAmerican-vs-Asian |
9.472000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.24910000001799E-06 |
| Normal-vs-Female |
1.243550E-03 |
| Male-vs-Female |
5.127600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.269700E-02 |
| Normal-vs-Extreme_Weight |
1.761770E-04 |
| Normal-vs-Obese |
1.699090E-03 |
| Normal-vs-Extreme_Obese |
2.581600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.214000E-01 |
| Normal_Weight-vs-Obese |
3.708800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.182200E-01 |
| Extreme_Weight-vs-Obese |
7.336200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.711600E-01 |
| Obese-vs-Extreme_Obese |
9.961000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.356000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.62039999995756E-06 |
| Normal-vs-Age(61-80Yrs) |
3.832000E-04 |
| Normal-vs-Age(81-100Yrs) |
2.222600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.752600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.514600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.865200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.625590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.125400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.061000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.55999998977074E-09 |
| Normal-VS-Type2 PRCC |
6.068100E-02 |
| Normal-VS-KIRP CIMP |
6.770300E-02 |
| Normal-VS-Unclassified PRCC |
1.300160E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.555400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.634400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.538000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.196200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.706200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.254100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.336400E-02 |
| Normal-vs-N1 |
6.772000E-01 |
| Normal-vs-N2 |
3.679400E-03 |
| N0-vs-N1 |
3.230000E-01 |
| N0-vs-N2 |
2.654600E-01 |
| N1-vs-N2 |
1.078770E-01 |
|
|
